Prospective analysis of safety and efficacy of medical cannabis in large unselected population of patients with cancer.

Citation data:

European journal of internal medicine, ISSN: 1879-0828, Vol: 49, Page: 37-43

Publication Year:
2018
Captures 28
Readers 28
Mentions 24
News Mentions 18
Blog Mentions 6
Social Media 855
Shares, Likes & Comments 589
Tweets 266
PMID:
29482741
DOI:
10.1016/j.ejim.2018.01.023
Author(s):
Bar-Lev Schleider, Lihi; Mechoulam, Raphael; Lederman, Violeta; Hilou, Mario; Lencovsky, Ori; Betzalel, Oded; Shbiro, Liat; Novack, Victor
Publisher(s):
Elsevier BV
Tags:
Medicine
Most Recent Tweet View All Tweets
Most Recent Blog Mention
Most Recent News Mention
article description
Cancer is a major public health problem as the leading cause of death. Palliative treatment aimed to alleviate pain and nausea in patients with advanced disease is a cornerstone of oncology. In 2007, the Israeli Ministry of Health began providing approvals for medical cannabis for the palliation of cancer symptoms. The aim of this study is to characterize the epidemiology of cancer patients receiving medical cannabis treatment and describe the safety and efficacy of this therapy.